PTGDR and neoplasm: As shown in Fig. 5a, FOXD3-AS1 knockdown suppressed the in vivo tumor growth of A549/DDP cells, and in the cisplatin-treated mice, FOXD3-AS1 knockdown caused a further suppression on the in vivo tumor growth of A549/DDP cells (Fig. 5a).